ArticleDiseases (Basel, Switzerland)2022
Article in Diseases (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 12 citations in OpenAlex.
- Cancer incidence in the Pijao indigenous population of colombia using administrative health records, 1996-2022.Scientific reports · 2026Article
- Article
- Review
- Whole-genome sequencing ofMicrobiology resource announcements · 2024Article
- New strategies for Helicobacter pylori isolation and sequencing analysis for virulence genes contributing to its pathogenicity.Molecular biology reports · 2024Article
- Incidence of Stomach, Liver, and Colorectal Cancers by Geography and Social Vulnerability Among American Indian and Alaska Native Populations, 2010-2019.American journal of epidemiology · 2024Article
- The prevalence and risk factors ofMicrobiota in health and disease · 2024Article
- Infectious diseases in Indigenous populations in North America: learning from the past to create a more equitable future.The Lancet. Infectious diseases · 2023Review
- Antibiotic Resistance Rates forMicroorganisms · 2023Article
- Molecular characterization ofSaudi medical journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundIn Arizona
aimThe aim of this study was to estimate the prevalence of specific
methodsVirulence genes,
results
conclusions
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.